Doxorubicin Induced Hepatotoxicity, Apoptosis and Renal Dysfunction: Role of Hesperidin in Potentiation or Attenuation in Male Wistar Rats
DOI:
https://doi.org/10.14738/bjhr.1201.18159Keywords:
Doxorubicin, hepatotoxicity, nephrotoxicity, hesperidin, apoptosisAbstract
The common side effect of doxorubicin use in the treatment of neoplasms is cardio-hepatotoxicity and nephrotoxicity among others. Other treatment measures has been sort to alleviate the outrageous suffering of cancer patients. Hesperidin, a natural plant product from citrus plants has an antioxidant and protective property. The aim of the study was to find out the effect of hesperidin and captopril on doxorubicin induced liver and kidney injury as well as apoptotic activity. In this study, twenty five male Wistar rats weighing 160-180g were randomly selected into five groups (G1-G5)containing five rats each. G1 (control), received normal feed, G2 received 5mg/kg body weight of Doxorubicin(doxo) orally. G3 received 50mg/kg of hesperidin, G4 received 5mg/kg body weight of Doxorubicin(doxo)plus Hesp. While G5 received 5mg/kg body weight of Doxorubicin(doxo)plus Captopril(oral). Treatment lasted for 28 days. Blood samples were collected via cardiac puncture and centrifuged at 1000rpm for 10minutes. Results obtained showed elevated levels of malondialdehyde, Urea, creatinine and total proteins. Liver enzymes (AST, ALT, ALP, GGT), Caspase 3, Bax and Bcl2 were significantly (p<0.05) raised. Treatment with hesperidin and captopril respectively, significantly (p<0.05) decreased the parameters in all treatment groups when compared to doxo group. We conclude that hesperidin transiently attenuates apoptosis and ameliorates toxic effects of doxorubicin on the liver and kidney .
References
Warpe VS, Mali VR, Arulmozhi S, Bodhankar SL, Mahadik KR. Cardioprotective effect of ellagic acid on doxorubicin induced cardiotoxicity in wistar rats. J Acute Med. 2015;5(1):1–8.
Kciuk, M.; Gielecińska, A.; Mujwar, S.; Kołat, D.; Kałuzińska-Kołat, Ż.; Celik, I.; Kontek, R. Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity. Cells 2023, 12, 659.
Walaa A. Negm, M. El-Aasr, G. Attia, M.J. Alqahtani, R.I. Yassien, A. Abo Kamer, E. Elekhnawy Promising antifungal activity of Encephalartos laurentianus de Wild against Candida albicans clinical isolates: in vitro and in vivo effects on renal cortex of adult albino rats J. Fungi, 8 (5) (2022), p. 426
Alotaibi, B.; El-Masry, T.A.; Elekhnawy, E.; El-Kadem, A.H.; Saleh, A.; Negm, W.A.; Abdelkader, D.H. Aqueous core epigallocatechin gallate PLGA nanocapsules: Characterization, antibacterial activity against uropathogens, and in vivo reno-protective effect in cisplatin-induced nephrotoxicity. Drug Deliv. 2022, 29, 1848–1862.
Shokrzadeh, M.; Bagheri, A.; Ghassemi-Barghi, N.; Rahmanian, N.; Eskandani, M. Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2021, 394, 1803–1813.
Liu, X. H. Bian, H. Q.-L. Dou, X.-W. Huang, W.-Y. Tao, W.-H. Liu, N. Li, W.-W. Zhang, Ginkgetin alleviates inflammation, oxidative stress, and apoptosis induced by hypoxia/reoxygenation in H9C2 cells via caspase-3 dependent pathway, BioMed Res. Int., 2020,
Prasanna, P.L.; Renu, K.; Gopalakrishnan, A.V. New molecular and biochemical insights of doxorubicininduced hepatotoxicity. Life Sci. 2020, 250, 117599.
Karaman, A.; Fadillioglu, E.; Turkmen, E.; Tas, E.; Yilmaz, Z. Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver. Pediatr. Surg. Int. 2006, 22, 428–434.
Waseem, M.; Tabassum, H.; Bhardwaj, M.; Parvez, S. Ameliorative efficacy of quercetin against cisplatininduced mitochondrial dysfunction: Study on isolated rat liver mitochondria. Mol. Med. Rep. 2017, 16,
Mansouri, E.; Jangaran, A.; Ashtari, A. Protective effect of pravastatin on doxorubicin-induced hepatotoxicity. Bratisl. Lek. Listy 2017, 118, 273–277.
Marchand, D.J.; Renton, K.W. Depression of cytochrome P-450-dependent drug biotransformation by adriamycin. Toxicol. Appl. Pharmacol. 1981, 58, 83–88.
Carvalho, C.; Santos, R.X.; Cardoso, S.; Correia, S.; Oliveira, P.J.; Santos, M.S.; Moreira, P.I. Doxorubicin: The Good, the Bad and the Ugly Effect. Curr. Med. Chem. 2009, 16, 3267–3285.
Ayla, S I. Seckin, G. Tanriverdi, M. Cengiz, M. Eser, B.C. Soner, G. Oktem Doxorubicin induced nephrotoxicity: protective effect of nicotinamide Int. J. Cell Biol., 2011 (2011), Article 390238
Wapstra F.H., van Goor H., de Jong P.E., Navis G., de Zeeuw D. Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis. J. Pharmacol. Toxicol. Methods. 1999; 41:69–73. doi: 10.1016/s1056-8719(99)00015-5.
Xing, W. Wen C. Wang, D. H. Shao, C. Liu, C. He, O.J. Olatunji. Cardiorenal protective effect of costunolide against doxorubicin-induced toxicity in rats by modulating oxidative stress, inflammation and apoptosis. Molecules, 27 (7) (2022), p. 2122
Baliou, S.; Adamaki, M.; Ioannou, P.; Pappa, A.; Panayiotidis, M.I.; Spandidos, D.A.; Christodoulou, I.; Kyriakopoulos, A.M.; Zoumpourlis, V. Protective role of taurine against oxidative stress (Review). Mol. Med. Rep. 2021, 24, 1–19.
Akhlaghipour, A. Nasimi Shad, V.R. Askari, V. Baradaran Rahimi Daidzin and its de-glycosylated constituent daidzein as a potential therapeutic for cardiovascular diseases: A review from bench to bed Phytotherapy Research (2024),10.1002/ptr.8261
Wang, Y.; Mei, X.; Yuan, J.; Lu, W.; Li, B.; Xu, D. Taurine zinc solid dispersions attenuate doxorubicininduced hepatotoxicity and cardiotoxicity in rats. Toxicol. Appl. Pharmacol. 2015, 289, 1–11.
Askari, V.R. Baradaran Rahimi V, Assaran, A, Iranshahi,M ,Boskabady,M.H: Evaluation of the anti-oxidant and anti-inflammatory effects of the methanolic extract of Ferula szowitsiana root on PHA-induced inflammation in human lymphocytes Drug and Chemical Toxicology, 43 (4) (2020), pp. 353-360, 10.1080/01480545.2019.1572182
Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351–358.
Nam, J.; Son, S.; Ochyl, L.J.; Kuai, R.; Schwendeman, A.; Moon, J.J. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer. Nat. Commun. 2018, 9, 1074.
Rivankar, S. An overview of doxorubicin formulations in cancer therapy. J. Cancer Res. Ther. 2014, 10,
Chen, X.; Zhang, Y.; Zhu, Z.; Liu, H.; Guo, H.; Xiong, C.; Xie, K.; Zhang, X.; Su, S. Protective effect of berberine on doxorubicininduced acute hepatorenal toxicity in rats. Mol. Med. Rep. 2016, 13, 3953–3960. 352
Owumi, S.E.; Lewu, D.O.; Arunsi, U.O.; Oyelere, A.K. Luteolin attenuates doxorubicin-induced derangements of liver and kidney by reducing oxidative and inflammatory stress to suppress apoptosis. Hum. Exp. Toxicol. 2021, 40, 1656–1672.
Jasim, S.T.; Al-Kuraishy, H.M.; Al-Gareeb, A.I. Gingko Biloba protects cardiomyocytes against acute doxorubicin induced cardiotoxicity by suppressing oxidative stress. J. Pak. Med. Assoc. 2019, 69 (Suppl. S3), S103–S107.
Fard, M.H.; Ghule, A.E.; Bodhankar, S.L.; Dikshit, M. Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat. Pharm. Biol. 2011, 49, 377–382.
Tsikas, D. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges. Anal. Biochem. 2017, 524, 13–30.
Abdelmeguid N.E., Chmaisse H.N., Zeinab N.A. Protective effect of silymarin on cisplatin-induced nephrotoxicity in rats. Pak. J. Nutr. 2010;9:624–636.
Abd-Ellatif, RN; N.A. Nasef, H.E.S. El-Horany, M.N. Emam, R.L. Younis, R.E.A. El Gheit, W. Elseady, D.A. Radwan, Y.M. Hafez, A. Eissa, et al. Adrenomedullin mitigates doxorubicin-induced nephrotoxicity in rats: role of oxidative stress, inflammation, apoptosis, and pyroptosis. Int. J. Mol. Sci., 23 (2022), p. 14570
Tacar O, Sriamornsak P, Dass CR. Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. Journal of Pharmacy and Pharmacology. J Pharm Pharmacol. 2013;65(2):157–70.
Lu, J.; Li, J.; Hu, Y.; Guo, Z.; Sun, D.; Wang, P.; Guo, K.; Duan, D.D.; Gao, S.; Jiang, J.; et al. Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation. Acta Pharm. Sin. B 2019, 9, 782–793. [Google Scholar] [CrossRef]
Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011 Jul 19;21(1):92-101.
Ullah, A.; Munir, S.; Badshah, S.L.; Khan, N.; Ghani, L.; Poulson, B.G.; Emwas, A.; Jaremko, M. Important Flavonoids and Their Role as a Therapeutic Agent. Molecules 2020, 25, 5243.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ada Akwari, Esther George, Ukwula Obia, Moses Nyirenda, Reuben Mbuki, Etah E. Nkanu
This work is licensed under a Creative Commons Attribution 4.0 International License.
